![Dvorit Samid](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dvorit Samid currently works at Aardvark Therapeutics, Inc., as Executive Vice President-Medical Affairs.
Dr. Samid also formerly worked at Synta Pharmaceuticals Corp., as Vice President-Medical Affairs and NantKwest, Inc., as Senior Vice President-Medical Affairs.
Dr. Samid received her doctorate degree from The Catholic University of America and undergraduate degree from The Hebrew University of Jerusalem.
| Companies | Position | Start |
|---|---|---|
| AARDVARK THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
| Companies | Position | End |
|---|---|---|
| IMMUNITYBIO, INC. | Chief Tech/Sci/R&D Officer | - |
Synta Pharmaceuticals Corp.
 Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 5 |
|---|---|
Synta Pharmaceuticals Corp.
Synta Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes novel pharmaceutical products | Health Technology |
NantKwest, Inc.
 NantKwest, Inc. BiotechnologyHealth Technology Develops and produces cancer treatment products | Health Technology |
The Catholic University of America
 The Catholic University of America Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Hebrew University of Jerusalem
 The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Aardvark Therapeutics, Inc.
 Aardvark Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel small molecule therapeutics for obesity and metabolic diseases | Health Technology |
Select your edition
All financial news and data tailored to specific country editions
